Jaguar Health, Inc.
JAGX
$1.02
-$0.14-12.07%
NASDAQ
| 09/30/2025 | 06/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 3.49% | 34.55% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 3.49% | 34.55% | |||
| Cost of Revenue | 0.95% | 2.33% | |||
| Gross Profit | 4.04% | 44.32% | |||
| SG&A Expenses | -14.78% | -2.65% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -6.05% | -5.58% | |||
| Operating Income | 9.60% | 15.01% | |||
| Income Before Tax | 8.64% | 0.34% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 8.64% | 0.34% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -4.58% | 15.91% | |||
| Net Income | 8.70% | 0.54% | |||
| EBIT | 9.60% | 15.01% | |||
| EBITDA | 10.23% | 15.80% | |||
| EPS Basic | 38.77% | 38.58% | |||
| Normalized Basic EPS | 25.66% | 49.50% | |||
| EPS Diluted | 38.77% | 38.58% | |||
| Normalized Diluted EPS | 25.66% | 49.50% | |||
| Average Basic Shares Outstanding | 49.11% | 61.95% | |||
| Average Diluted Shares Outstanding | 49.11% | 61.95% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||